Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein - PubMed (original) (raw)
. 2001 Nov 1;167(9):4801-4.
doi: 10.4049/jimmunol.167.9.4801.
Affiliations
- PMID: 11673482
- DOI: 10.4049/jimmunol.167.9.4801
Free article
Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein
S Khan et al. J Immunol. 2001.
Free article
Abstract
CTLs recognize peptide epitopes which are proteolytically generated by the proteasome and presented on MHC class I molecules. According to the defective ribosomal product (DRiP) hypothesis, epitopes originate from newly synthesized polypeptides which are degraded shortly after their translation. The DRiP hypothesis would explain how epitopes can be generated from long-lived proteins. We examined whether neosynthesis is required for presentation of the immunodominant epitope NP118 of the lymphocytic choriomeningitis virus nucleoprotein, which has a half-life of >3 days. Two days after nucleoprotein biosynthesis was terminated in a tetracycline-regulated transfectant, the presentation of the NP118 epitope ceased. This indicates that NP118 epitopes are generated from newly synthesized nucleoproteins rather than from the long-lived pool of nucleoproteins in the cell. Therefore, the lymphocytic choriomeningitis virus nucleoprotein is the first substrate for which a major prediction of the DRiP hypothesis, namely the requirement for neosynthesis, is shown to hold true.
Similar articles
- Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins.
Basta S, Stoessel R, Basler M, van den Broek M, Groettrup M. Basta S, et al. J Immunol. 2005 Jul 15;175(2):796-805. doi: 10.4049/jimmunol.175.2.796. J Immunol. 2005. PMID: 16002676 - Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
Schwarz K, van Den Broek M, Kostka S, Kraft R, Soza A, Schmidtke G, Kloetzel PM, Groettrup M. Schwarz K, et al. J Immunol. 2000 Jul 15;165(2):768-78. doi: 10.4049/jimmunol.165.2.768. J Immunol. 2000. PMID: 10878350 - Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE, Most Rv Rv, Whitton JL, Ahmed R. Harrington LE, et al. J Virol. 2002 Apr;76(7):3329-37. doi: 10.1128/jvi.76.7.3329-3337.2002. J Virol. 2002. PMID: 11884558 Free PMC article. - The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
Schwarz K, de Giuli R, Schmidtke G, Kostka S, van den Broek M, Kim KB, Crews CM, Kraft R, Groettrup M. Schwarz K, et al. J Immunol. 2000 Jun 15;164(12):6147-57. doi: 10.4049/jimmunol.164.12.6147. J Immunol. 2000. PMID: 10843664 Free PMC article. - Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames.
Bullock TN, Eisenlohr LC. Bullock TN, et al. J Exp Med. 1996 Oct 1;184(4):1319-29. doi: 10.1084/jem.184.4.1319. J Exp Med. 1996. PMID: 8879204 Free PMC article.
Cited by
- Cellular stress increases DRIP production and MHC Class I antigen presentation.
Pach N, Basler M. Pach N, et al. Front Immunol. 2024 Aug 23;15:1445338. doi: 10.3389/fimmu.2024.1445338. eCollection 2024. Front Immunol. 2024. PMID: 39247192 Free PMC article. - Hyperthermia and Tumor Immunity.
Adnan A, Muñoz NM, Prakash P, Habibollahi P, Cressman ENK, Sheth RA. Adnan A, et al. Cancers (Basel). 2021 May 21;13(11):2507. doi: 10.3390/cancers13112507. Cancers (Basel). 2021. PMID: 34063752 Free PMC article. Review. - Viruses, cancer and non-self recognition.
Padariya M, Kalathiya U, Mikac S, Dziubek K, Tovar Fernandez MC, Sroka E, Fahraeus R, Sznarkowska A. Padariya M, et al. Open Biol. 2021 Mar;11(3):200348. doi: 10.1098/rsob.200348. Epub 2021 Mar 31. Open Biol. 2021. PMID: 33784856 Free PMC article. Review. - Combining radiotherapy and immunotherapy in definitive treatment of head and neck squamous cell carcinoma: review of current clinical trials.
Plavc G, Strojan P. Plavc G, et al. Radiol Oncol. 2020 Oct 11;54(4):377-393. doi: 10.2478/raon-2020-0060. Radiol Oncol. 2020. PMID: 33064670 Free PMC article. Review. - Surprisingly Effective Priming of CD8+ T Cells by Heat-Inactivated Vaccinia Virus Virions.
Croft S, Wong YC, Smith SA, Flesch IEA, Tscharke DC. Croft S, et al. J Virol. 2020 Sep 29;94(20):e01486-20. doi: 10.1128/JVI.01486-20. Print 2020 Sep 29. J Virol. 2020. PMID: 32759313 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials